These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6107677)

  • 21. [Long-term results of treatment of obesity].
    Wechsler JG; Ditschuneit H
    Med Klin; 1980 Jul; 75(15):544-50. PubMed ID: 7001202
    [No Abstract]   [Full Text] [Related]  

  • 22. A clinical trial of a new fenfluramine preparation (Ponderax PA).
    Hooper AC
    Postgrad Med J; 1975; 51 Suppl 1():159-60. PubMed ID: 768960
    [No Abstract]   [Full Text] [Related]  

  • 23. Prolonged weight loss with dexfenfluramine treatment in obese patients.
    Finer N; Craddock D; Lavielle R; Keen H
    Diabete Metab; 1987; 13(6):598-602. PubMed ID: 3329122
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of obesity with fenfluramine.
    Schindler H; Bielesz G
    Wien Med Wochenschr; 1975 Jan; 125(5):85-8. PubMed ID: 1124579
    [No Abstract]   [Full Text] [Related]  

  • 25. Echocardiographic improvement over time after cessation of use of fenfluramine and phentermine.
    Hensrud DD; Connolly HM; Grogan M; Miller FA; Bailey KR; Jensen MD
    Mayo Clin Proc; 1999 Dec; 74(12):1191-7. PubMed ID: 10593346
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fenfluramine, vitamin C and weight loss.
    Wilson CW; Foran K; Innes JA; Watson ML; Ford MJ; Stoddart ME; Munro JF
    Int J Obes; 1978; 2(4):463-5. PubMed ID: 370042
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fenfluramine in Prader-Willi syndrome: a double blind, placebo controlled trial.
    Selikowitz M; Sunman J; Pendergast A; Wright S
    Arch Dis Child; 1990 Jan; 65(1):112-4. PubMed ID: 2405783
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A three year follow-up of a behavioral treatment for obesity.
    Götestam KG
    Addict Behav; 1979; 4(2):179-83. PubMed ID: 474267
    [No Abstract]   [Full Text] [Related]  

  • 29. Long-term weight control study. V (weeks 190 to 210). Follow-up of participants after cessation of medication.
    Weintraub M; Sundaresan PR; Schuster B; Averbuch M; Stein EC; Byrne L
    Clin Pharmacol Ther; 1992 May; 51(5):615-8. PubMed ID: 1587076
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of caloric restriction and fenfluramine on weight loss and personality profiles of patients with long standing obesity.
    Goldrick RB; Havenstein N; Whyte HM
    Aust N Z J Med; 1973 Apr; 3(2):131-41. PubMed ID: 4146050
    [No Abstract]   [Full Text] [Related]  

  • 31. Fenfluramine in obese patients on various antihypertensive drugs. Double-blind controlled trial.
    Waal-Manning HJ; Simpson FO
    Lancet; 1969 Dec; 2(7635):1392-5. PubMed ID: 4188278
    [No Abstract]   [Full Text] [Related]  

  • 32. Sequencing of behavior therapy and pharmacotherapy for obesity.
    Craighead LW
    J Consult Clin Psychol; 1984 Apr; 52(2):190-199. PubMed ID: 6715646
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of 6 months therapy with dexfenfluramine in obese patients: studies in the United Kingdom.
    Finer N; Craddock D; Lavielle R; Keen H
    Clin Neuropharmacol; 1988; 11 Suppl 1():S179-86. PubMed ID: 3052816
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vitamin C and the anti-obesity effect of fenfluramine.
    Odumosu A; Wilson CW
    Int J Vitam Nutr Res; 1979; 49(3):251-63. PubMed ID: 528154
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Health-related quality of life in obese outpatients losing weight with very-low-energy diet and behaviour modification--a 2-y follow-up study.
    Kaukua J; Pekkarinen T; Sane T; Mustajoki P
    Int J Obes Relat Metab Disord; 2003 Oct; 27(10):1233-41. PubMed ID: 14513072
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combination of diet, exercise and intermittent treatment of cimetidine on body weight and maintenance of weight loss. A 42 months follow-up study.
    Birketvedt GS; Thom E; Bernersen B; Florholmen J
    Med Sci Monit; 2000; 6(4):699-703. PubMed ID: 11208394
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term treatment with fenfluramine in obese subjects.
    Sensi S; Della Loggia F; Del Ponte A; Guagnano MT
    Int J Clin Pharmacol Res; 1985; 5(4):247-53. PubMed ID: 4055167
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drugs and diet therapy.
    Stunkard A
    Curr Concepts Nutr; 1983; 12():169-74. PubMed ID: 6342971
    [No Abstract]   [Full Text] [Related]  

  • 39. Platelet alpha-adrenergic receptors in obesity: alteration with weight loss.
    Sundaresan PR; Weintraub M; Hershey LA; Kroening BH; Hasday JD; Banerjee SP
    Clin Pharmacol Ther; 1983 Jun; 33(6):776-85. PubMed ID: 6303674
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.